Rhythm Pharmaceuticals Inc (RYTM)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Rhythm Pharmaceuticals Inc-Aktie (RYTM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	48.31% 48.50	32.70	41.83	33.25	29.08
Cost Of Revenue	51.95% 5.543	3.648	3.787	3.828	2.947
Gross Profit	47.85% 42.96	29.06	38.04	29.42	26.13
Operating Expenses	16.03% 88.25	76.06	79.30	73.31	66.61
Benefits Costs and Expenses	15.43% 94.80	82.12	85.21	77.24	60.86
Costs And Expenses	17.68% 93.80	79.71	83.08	77.14	69.56
Operating Income/Loss	3.63% -45.30	-47.00	-41.26	-43.88	-40.48
Nonoperating Income/Loss	58.62% -0.999	-2.414	-2.127	-0.10	8.696
Income/Loss From Continuing Operations Before Tax	6.32% -46.30	-49.42	-43.38	-43.98	-31.78
Income Tax Expense/Benefit	321.25% 0.337	0.08	-0.09	-0.344	0.479
Income/Loss From Continuing Operations After Tax	5.79% -46.63	-49.50	-43.29	-43.64	-32.26
Net Income/Loss	5.79% -46.63	-49.50	-43.29	-43.64	-32.26
Preferred Stock Dividends And Other Adjustments	1.349	-	1.339	1.329	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.99% 63.68	63.06	0.2019	61.22	61.01
Diluted Average Shares	0.99% 63.68	63.06	0.2019	61.22	61.01
Basic Earnings Per Share	7.41% -0.75	-0.81	-0.72	-0.73	-0.55
Diluted Earnings Per Share	7.41% -0.75	-0.81	-0.72	-0.73	-0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	1.349	-	1.339	1.329	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%